public expenditure

Filter by
 

Type of content

Publication date

Keywords

Keywords

Target audience

Displaying 1 - 20 of 25
close-up of a Euro note
Topics

Public expenditure

22.01.2020

Estimating drug-related public expenditure and developing the economic evaluation of drug policy have been on the European agenda for more than a decade. However, only a few countries have produced comprehensive estimates of drug-related public expenditure. Moreover, those who have done it have...
Events
Events

International Conference on Health Care Expenditure

23.10.2019

The EMCDDA will be present at the International Conference on Health Care Expenditure which is taking place in Santiago de Compostela, Spain.
Publications

Financial regulation of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

27.06.2019

This regulation lays down the essential financial rules for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). It is based on and does not depart from the Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework financial regulation for the bodies set...
Publications

European Drug Report 2019: Trends and Developments

06.06.2019

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug...
Publications

2019 Country Drug Reports

06.06.2019

Country Drug Reports provide a top-level overview of the drug phenomenon in European countries, covering topics such as drug supply, drug use and public health problems as well as drug policy and responses. Each Country Drug Report focuses on a single country (28 EU Member States as well as Norway...
drug related expenditure
Media library

Infographic: drug-related public expenditure: estimated breakdown between demand reduction and supply reduction

06.06.2019
Publications

European Drug Report 2018: Trends and Developments

07.06.2018

The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2018 European Drug...
publication thumnail
Publications

2018 Country Drug Reports

07.06.2018

Country Drug Reports provide a top-level overview of the drug phenomenon in European countries, covering topics such as drug supply, drug use and public health problems as well as drug policy and responses. Each Country Drug Report focuses on a single country (28 EU Member States as well as Norway...
Chart showing most recent estimates of drug-related public expenditure (% GDP)
Media library

Infographic: most recent estimates of drug-related public expenditure (% GDP)

07.06.2018
cover page
Publications

Drug treatment expenditure: a methodological overview

18.10.2017

It is estimated that over 1 million people receive treatment for drug-related problems in the European Union every year. With shrinking public budgets, increasing pressure on health systems, changes in the drugs used and the need to provide on-going care to chronic cases, what is the real cost of...
News

How to estimate the cost of drug treatment in Europe?

18.10.2017

It is estimated that over 1 million people receive treatment for drug-related problems in the European Union every year. With shrinking public budgets, increasing pressure on health systems, changes in the substances used and the need to provide ongoing care to chronic cases, how can we estimate...
cover publication
Publications

Public expenditure on supply reduction policies

23.06.2017

Evaluating drug policy is an integral part of a cost-efficient approach to tackle illicit drugs. This report takes a first step towards a systematic analysis, by examining a set of representative attempts to estimate public expenditure on supply reduction interventions. It proposes a common set of...
Document library
Document library

HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden

13.12.2016

In Hungary a large increase in injecting new psychoactive substances (NPS) coincided with decreasing harm reduction efforts and rising HCV infection. NPS injectors in Hungary are at severe risk of...
Document library
Document library

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

26.01.2016

In June 2014 the Athens High Level Meeting discussed recent policy developments, persisting and emerging challenges related to the prevention and management of viral hepatitis and the need for a de...
Financing drug policy in Europe in the wake of the economic recession
Publications

Financing drug policy in Europe in the wake of the economic recession

01.12.2014

The economic crisis that Europe experienced in 2008 and later presented a grave challenge to public finances. Countries responded to this by undertaking fiscal consolidation. By examining public expenditure in the areas where most drug-related activities are provided, this report looks at how...
Events
Events

Reitox Academy on ‘Drug related expenditures’ in Israel

30.09.2014

This Reitox Academy was organised in close cooperation with the Israel Anti-Drug Authority (IADA). The objectives were to better understand the EMCDDA role within and beyond the European Union and...
Publications

Estimating public expenditure on drug-law offenders in prison in Europe

01.02.2014

This study estimates how much 22 European countries spent on drug-law offenders in prisons during the last decade. Based on this, an estimate for public expenditure on drug-law offenders at the European level was made.
Map showing examples of mass media campaigns in different countries
Media library

Interactive: examples of mass media campaigns in different countries in Europe

28.05.2013
Document library
Document library

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

18.04.2013

The prevalence of chronic HBV and HCV infection varies widely between European countries. Cost-effectiveness analyses may need to take effect of antiviral treatment on preventing HBV and HCV...
Publications

Cost and financing of drug treatment services in Europe

01.11.2011

This Selected issue provides an exploratory European overview of costs associated with treatment for drug dependence. The cost of drug treatment in Europe is looked at from two main angles in this report. First, an overview is presented of the main sources of funding for drug treatment and the...